首页 > 期刊检索 > 详细
      标题:FOS样抗原1在恶性肿瘤中的研究进展
      作者:王海波 综述 包珊 审校    海南省人民医院(海南医学院附属海南医院)妇科,海南 海口 570311
      卷次: 2021年32卷15期
      【摘要】 FOS样抗原 1 (FOSL1)是一种可以在人体内编码 FOSL1蛋白的基因,又称为 FOS 相关抗原 1(Fos-related antigen1,FRA1),是活性蛋白1复合物(AP-1)的组成部分,其编码的蛋白受多种信号通路调控,影响肿瘤的增殖、分化、侵袭和转移等多种生物学功能。已有研究证实,FOSL1参与了乳腺癌、结直肠癌、脑胶质瘤、宫颈癌等多种恶性肿瘤的恶性进展。
      【关键词】 FOS样抗原1;恶性肿瘤;增殖;转移;治疗耐药
      【中图分类号】 R73 【文献标识码】 A 【文章编号】 1003—6350(2021)15—2028—04

Research progress of FOS like antigen 1 in malignant tumors.

WANG Hai-bo, BAO Shan. Department of Gynaecology,Hainan General Hospital (Hainan Hospital Affiliated to Hainan Medical College), Haikou 570311, Hainan, CHINA【Abstract】 FOS-like antigen 1 (FOSL1) is a gene that can encode FOSL1 protein in human body, also known asFOS related antigen 1 (FRA1). It is a component of active protein-1 complex (AP-1). The protein encoded by FOSL1 isregulated by a variety of signal pathways, affecting the proliferation, differentiation, invasion and metastasis of tumorand other biological functions. It has been confirmed that FOSL1 is involved in the malignant progress of breast cancer,colorectal cancer, glioma, cervical cancer and other malignant tumors. This article mainly reviews the regulation of FO-SL1 and its biological role in the proliferation and metastasis of various tumors.
      【Key words】 FOS-like antigen 1 (FOSL1); Malignant tumor; Proliferation; Transfer; Treatment resistance·综述·doi:10.3969/j.issn.1003-6350.2021.15.033

       下载PDF